Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 170

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 170
---
U. S. dollars, unless stated otherwise)

Disaggregated
information of revenues by regions are as follows:

Schedule
of disaggregated information of revenues by region

                 2024                                                 2023                     2022                 
                 For the Years Ended December 31,                                                                   
                 2024                                                 2023                     2022                 
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Singapore      $                                     3,921,982      $         3,706,458      $         3,764,295  
  Malaysia                                                89,023                                                    
  Total          $                                     4,011,005      $         3,706,458      $         3,764,295  

As
of December 31, 2024, the Company’s total assets were comprised of $ 279,515 1,173,979 244,316

As
of December 31, 2023, the Company’s total assets were comprised of $ 597,090 102,839 610,579

Note
22 - Subsequent events

The
Company evaluated all events and transactions that occurred after December 31, 2024 up through April 29, 2025, the date the Company issued
these consolidated financial statements.

From
January 2025 to April 2025, the Company entered into ten loan agreements with 8i Enterprises Pte Ltd, a related party, for an aggregate
principal amount of $ 768,942 8

In March 2025, the Company entered a loan agreements with 8i Asia Limited,
a third party, for an aggregate principal amount of $ 46,293

In March 2025, the Company entered into a loan agreements with Alfred Lim, a
related party, for an aggregate principal amount of $ 35,855 8

Other
than the events described above, the Company did not identify any additional subsequent events that would require disclosure.

  F-51